Mural Oncology plc
MURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $3,512 | $2,567 | $0 | $1,474 |
| Gross Profit | -$3,512 | -$2,567 | $0 | -$1,474 |
| % Margin | – | – | – | – |
| R&D Expenses | $110,666 | $162,032 | $167,191 | $159,817 |
| G&A Expenses | $27,596 | $30,706 | $17,732 | $15,548 |
| SG&A Expenses | $27,596 | $30,039 | $17,732 | $15,548 |
| Sales & Mktg Exp. | $0 | -$667 | $0 | $0 |
| Other Operating Expenses | -$3,512 | $0 | $0 | -$1,474 |
| Operating Expenses | $134,750 | $192,071 | $184,923 | $173,891 |
| Operating Income | -$138,262 | -$194,638 | -$184,923 | -$175,365 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $9,748 | -$649 | $0 | $0 |
| Pre-Tax Income | -$128,514 | -$195,287 | -$184,923 | -$175,365 |
| Tax Expense | $0 | $12,160 | $4,884 | $68 |
| Net Income | -$128,514 | -$207,447 | -$189,807 | -$175,433 |
| % Margin | – | – | – | – |
| EPS | -7.58 | -12.43 | -11.37 | -10.51 |
| % Growth | 39% | -9.3% | -8.2% | – |
| EPS Diluted | -7.58 | -12.43 | -11.37 | -10.51 |
| Weighted Avg Shares Out | 16,955 | 16,690 | 16,688 | 16,688 |
| Weighted Avg Shares Out Dil | 16,955 | 16,690 | 16,688 | 16,688 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9,748 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3,512 | $2,567 | $1,540 | $1,474 |
| EBITDA | -$125,002 | -$192,720 | -$183,383 | -$173,891 |
| % Margin | – | – | – | – |